Amit Sehrawat

Dr. Amit Sehrawat

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2021 in South Asian Journal of Cancer
Verified
Journal Article
Open access
PDF file
GMGyanendra Swaroop Mittal
Gyanendra Swaroop Mittal
DSDeepak Sundriyal
Deepak Sundriyal
NNNiranjan B. Naik
Niranjan B. Naik
ASAmit Sehrawat
Amit Sehrawat
Background Chemoport (totally implantable venous access device) and its catheter system are used to administer long-term chemotherapy in cancer patients. The objective of this study was to analyze the complications associated with chemoport insertion in various cancer patients. Material and Methods A total number of 168 chemoports along with polyurethane catheters were inserted in various cancer patients over a period of 3 years. 9.6 F polyurethane catheters were put by a team of surgical oncologists in operation theater under general or local anesthesia. Analysis of the complications was done until the chemoport was removed due to any reason. Results Out of 168 patients, 30 (17.85%) developed complications. Complications included arterial puncture, malposition of the catheter tip, pneumothorax, hematoma, seroma, deep vein thrombosis, fracture of the catheter, a reversal of port, infections, and thrombosis of the catheter. Only a few required premature port and catheter removal. Conclusion There was a low rate of complications associated with chemoport using a polyurethane type of catheter system. However, infection-related complications were comparatively more common in our series. Chemoport requires expert handling, patient education, strict follow-up, and dedicated teamwork to minimize complications.

19 October 2020 in Cancer Reports
Verified
Journal Article
Open access
PDF file
PKParmod Kumar
Parmod Kumar
MMMegha K Mukundan
Megha K Mukundan
ASAmit Sehrawat
Amit Sehrawat
DSDeepak Sundriyal
Deepak Sundriyal
Background: Tripe palms (TP) is one of the rare cutaneous paraneoplastic manifestations of various intra‐abdominal malignancies. TP and malignant acanthosis nigricans (MAN) occur together and may precede even years before the index cancer. Though rare, the clinical significance of TP and MAN holds significance as an indicator of internal malignancy.Case: Here, we describe 71‐year, postmenopausal female with ovarian cancer who presented to us with a history of dyspepsia, abdominal distension, and weight loss. On detailed history and evaluation, it was found that she had TP and MAN 4 years before diagnosis.Conclusion: The unique presentation preceding the primary illness necessitates extensive early work‐up to look for malignancy and the initial consideration for surgery due to the tumor biology in such patients.

26 December 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
SPSai Prasath
Sai Prasath
SHS. P. Harsha
S. P. Harsha
ASAnusha Mruthyunjaya Swamy
Anusha Mruthyunjaya Swamy
KJKarthik Jayalingappa
Karthik Jayalingappa
MKMayank Kapoor
Mayank Kapoor
UNUttam Kumar Nath
Uttam Kumar Nath

26 September 2024 in Indian Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MKMayank Kapoor
Mayank Kapoor
ASAnusha Mruthyunjaya Swamy
Anusha Mruthyunjaya Swamy
DSDeepak Sundriyal
Deepak Sundriyal
MKMridul Khanna
Mridul Khanna
NSNishant Sinha
Nishant Sinha
ASAmit Sehrawat
Amit Sehrawat

29 June 2021 in Indian Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
LALima Arya
Lima Arya
DSDeepak Sundriyal
Deepak Sundriyal
RBRekha Bhandari
Rekha Bhandari
RSRuchi Srivastava
Ruchi Srivastava
ASAmit Sehrawat
Amit Sehrawat

1 October 2024 in JCO Global Oncology
Verified
Journal Article
Open access
DSDeepak Sundriyal
Deepak Sundriyal
MKMayank Kapoor
Mayank Kapoor
PAPreeti Antil
Preeti Antil
SGSweety Gupta
Sweety Gupta
PKParmod Kumar
Parmod Kumar
ASAmit Sehrawat
Amit Sehrawat
PURPOSE: Desirable outcomes during the treatment of patients with cancer require adherence to evaluation, treatment, and follow-up. This study aimed to evaluate the factors associated with default in patients with cancer. MATERIALS AND METHODS: We included patients with a histologically confirmed diagnosis of cancer who defaulted during evaluation, treatment, and follow-up. All patients’ detailed demographic and clinical data were recorded. Those lost to follow-up were interviewed telephonically. The factors associated with default were noted. Descriptive statistics were used to compute the demographic and clinical characteristics. RESULTS: In total, 172 patients were included. Geriatric and female patients were 38.9% and 37.2%, respectively. Fifty-eight percent of the patients lived in rural areas, whereas 45.9% were illiterate. More than one third (34.3%) of the patients who defaulted received the curative-intent treatment, whereas 62.1% of patients had a good performance status immediately before default. The average distance traveled by the patients to reach the cancer facility was 143 ± 13.15 km. The most common reasons for default were the lack of social support, financial constraints, difficulty in commuting, and too sick to come in 45 (26.2%), 35 (20.3%), 28 (16.3%), and 23 (13.4%) patients, respectively. Twenty-nine (16.9%) patients reported more than one reason for default. CONCLUSION: Lack of social support, financial constraints, transportation barriers, and inadequate counseling by the health care provider serve as barriers to uninterrupted cancer care. These factors are often interrelated and can be attenuated by adopting the hub and spoke model. Simultaneously, a good relationship between the patient and the health care provider fostered by appropriate counseling is imperative to increase adherence to cancer treatment and improve the outcome.